MedPath

Care After Lymphoma (CALy) Trial: A phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care

Not Applicable
Completed
Conditions
ymphoma
Informational and practical needs
Depression
Anxiety
Stress
Self-empowerment
Lymphoma
Cancer - Hodgkin's
Cancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
Registration Number
ACTRN12615000530527
Lead Sponsor
niversity of Notre Dame Australia, Fremantle Campus
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Able to understand, read and write English
Pathologically confirmed new diagnosis of Hodgkin or non-Hodgkin lymphoma
Completed first line curative intent chemotherapy treatment or second line curative intent autologous transplant within the previous three months
No evidence of lymphoma on PET scan

Exclusion Criteria

Diagnosis of other haematological malignancy
Did not undergo chemotherapy treatment
Further treatment or follow-up at another hospital
Undergoing active treatment
Acute mental health condition that will preclude informed consent
Intellectually disabled
Comorbid condition that requires at least monthly visits with genral practitioner (GP)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath